Yıl: 2014 Cilt: 8 Sayı: 2 Sayfa Aralığı: 105 - 111 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Çölyak Hastalığı

Öz:
Çölyak hastalığı (ÇH) oldukça sık görülen bir hastalıktır. Klasik ÇH küçük yaşlarda ortaya çıkarken, atipik hastalık büyükçocuklarda ortaya çıkma eğilimindedir. Değişik klinik bulgular ve tanı- tarama yöntemleri hakkındaki bilgi birikimin artma- sı hastalıktan etkilenen çocukların erken tanı almasına ve uygun müdahalesine olanak sağlamıştır. Serolojik testler dahagüvenilir hale gelmesine rağmen, özellikle 2 yaş altındaki çocuklarda testlerle ilgili sorunlar devam etmektedir. Çölyakhastalarının büyük bir kısmı HLA DQ2 veya DQ8 kodlayan genleri taşırlar. Bu genlerin negatifliği ÇH olasılığını dışlamakiçin yararlı olabilir. Çölyak hastalığına tanı koymak için Glutensiz diyet başlanmadan önce, gluten içeren diyet altında du- odenal biyopsi yapılmalıdır. Glutensiz diyet asemptomatik olan hastalar da dahil ÇH tanısı alan tüm çocuklara verilmelidir.
Anahtar Kelime:

Konular: Pediatri

Celiac Disease

Öz:
Celiac disease is extremely common. The classical presentation tends to occur in younger children, while atypicalpresentations occur at an older age. Knowledge about the varied clinical manifestations together with CD screeningand diagnosis lead to appropriate early diagnosis and intervention in affected children. Although serologic testing hasbecome more reliable, there still remain significant problems with testing, particularly in children under 2 years old.Genes encoding HLA DQ2 or DQ8 are found in the vast majority of those with CD, and negative test results can beuseful in ruling out the disorder. All patients should undergo a duodenal biopsy while on a gluten-containing diet in orderto diagnose CD before a gluten-free diet (GFD) is recommended. A GFD should be offered to all children diagnosed withCD even when perceived as asymptomatic.
Anahtar Kelime:

Konular: Pediatri
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Trancone R, Jabri B. Celiac disease and gluten sensitivity. J Intern Med 2011;269:582-90.
  • 2. Lionetti E, Catassi C. New clues in celiac disease, epidemiyology, pathogenesis, clinical manifestations and treatment. Int Rev Immunol 2011; 30: 219-31.
  • 3. Demirçeken FG, Kansu A, Kuloğlu Z, Girgin N, Güriz H, Ensari A. Human tissue transglutaminase antibody screening by immunochomatographic line immunoassey for early diagnosis of celiac disease in Turkish children. Turk Gastroenterol 2008; 19: 14-21.
  • 4. Dalgıç B, Sarı S, Baştürk A, Ensari A, Eğritaş Ö, Bükülmez A, Barış Z. Prevalance of celiac disease in healthy Turkish school children. Am J Gastroenterol 2011; 106: 1512-7.
  • 5. Moore JK, West SR, Robins G. Advances in celiac disease. Curr Opin Gastroenterol 2011; 27:112-8.
  • 6. Dewar D, Pereira SP, Ciclitira PJ. The pathogenesis of celiac disease. Int J Biochem Cell Biol 2004; 36: 17-24.
  • 7. Akobeng AK, Heller FR. Assesing the population impact of low rates of breast feeding on asthma, ceoliac disease and obesity. Arch Dis Child 2007; 92: 583-5.
  • 8. Maiuri L, Ciacci C, Ricciardelli I. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003; 362: 30-7.
  • 9. Margaritte-Jeannin P, Babron MC, Bourgey M, Louka AS, Clot F, Percopo S, Coto I, et al. HLA-DQ relative risks for coeliac disease in European populations: A study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004; 63: 562-7.
  • 10. Salvati VM, Mac Donald TT, Vecchio Bianco G Del. Enhanced expression of interferon regulatory factor-1 in the mucosa of children with celiac disease. Pediatr Res 2008; 54: 312-8.
  • 11. Ravikumara M, Tuthill DP, Jenkins HR. Clinical presentation of coeliac disease. Arch Dis Child 2006; 91: 969-71.
  • 12. Lindfors K, Koskinen O, Kaukinen K. An update on the diagnosis of celiac disease. Int Rev Immunol 2011; 30: 185-96.
  • 13. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-60.
  • 14. Fasono A, Catassi C. Current approches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 2001; 120: 636-51.
  • 15. Tasco A, Salavati VM, Aricchio R, Maglio M, Borrelli M, Cruzzo A, et al. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol 2011; 9: 320-5.
  • 16. Holmes GK. Screening for ceoliac disease in type 1 diabetes. Arch Dis Child 2002;87:495-8.
  • 17. Larizza D, Calcaterrra V, De Giacomo C, De Silvstri A, Asti M, Badulli C, Autelli M, et al. Celiac disease in children with autoimmune thyroid disease. J Pediatr 2001;39: 738-40.
  • 18. Book L, Hart A, Black J, Feolo M, Zone J, Neuhausen SL. Prevalance and clinical characteristics of celiac disease in Down syndrome in a US study. Am J Med Genet 2001; 98: 70-4.
  • 19. Kaukinen K, LindforsK, Collin P, Koskinen O, Maki M. Coeliac disease diagnostic and therapeutic challenge. Clin Chem Lab Med 2010; 48: 1205-16. 20. Polanco I. Celiac disease. J Pediatr Gastroenterol Nutr 2008; 47: 283-7.
  • 21. Hill ID, Dirks MH, Liptak GS. Guideline for the diagnosis and treatment of celiac disease in children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19.
  • 22. Dahlbom I,Korponay-Szabo IR, Kovacs JB,  Szalai Z, Mäki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/ IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 2010;50:140–6.
  • 23. Hill PG, Holmes GK. Coeliac disease: A biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008;27:572–5.
  • 24. Vivas S, Ruiz de Morales JG, Riestra S, Arias L, Fuentes D, Alvarez N, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009;15:4775–80.
  • 25. Barbato M, Maiella G, Di Camillo C, Guida S, Valitutti F, Lastrucci G, et al. The anti-deamidated gliadin peptide antibodies unmask celiac disease in small children with chronic diarrhoea. Dig Liver Dis 2011;436:465-9.
  • 26. Kurppa K, Collin P, Lindfors K, Maki M, Kaukinen K. Spontaneous negative seroconversion of endomysial antibodies does not exclude subsequent celiac disease. J Pediatr Gastroenterol Nutr 2011; 53: 576-9.
  • 27. Karell K, Louka AS, Moodie SJ, Moodie SJ, Ascher H, Clot F, et al. HLA types in celiac disease patients not carrying the DQA1_05- DQB1_02 (DQ2) heterodimer: Results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469–77.
  • 28. Vidales MC, Zubillaga P, Zubillaga I, Alfonso-Sánchez MA. Allele and haplotype frequencies for HLA class II (DQA1 and DQB1) loci in patients with celiac disease from Spain. Hum Immunol 2004;65:352–8.
  • 29. Ensari A. Gluten sensitive enteropathy: Controversies in diagnosis and classification. Arch Pathol Lab Med 2010; 134: 826-36.
  • 30. Villanacci V, Ceppa P, Tavani E, Vindigni C, Volta U, Gruppo Italiano Patologi Apparato Digerente (GIPAD), Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Coeliac disease: The histology report. Dig Liver Dis 2011; 43: S385-95.
  • 31. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-94.
  • 32. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 375: 1731-43.
  • 33. Fric P, Gabrovska, Nevoral J. Celiac disease, gluten-free diet, and oats. Nutr Rev 2011; 69: 107-15.
  • 34. Catassi C, Bearzi I, Holems GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005; 128: S79-86.
  • 35. Wegner G, Berger G, Sinnereich U, Grylli V, Schober E, Huber WD, et al. Quality of life in adolescents with treated celiac disease: Influence of compliance and age at diagnosis. J Pediatr Gastroenterol Nutr 2008;47(5):555-61.
  • 36. Haines ML, Anderson PR, Gibson PR. The evidence base for long term management of celiac disease. Aliment Pharmacol Ther 2008; 28:1024-66.
  • 37. Jatla M, Zemel BS, Bierly P, Verma R. Bone mineral content deficits of the spine and whole body in children at time of diagnosis with celiac disease. J Pediatr Gasroenterol Nutr 2009; 48: 175-80.
  • 38. Moore JK, West SR, Robins G. Advances in celiac disease. Curr Opin Gastroenterol 2011; 27: 112-8.
APA KULOĞLU Z (2014). Çölyak Hastalığı. , 105 - 111.
Chicago KULOĞLU Zafer Çölyak Hastalığı. (2014): 105 - 111.
MLA KULOĞLU Zafer Çölyak Hastalığı. , 2014, ss.105 - 111.
AMA KULOĞLU Z Çölyak Hastalığı. . 2014; 105 - 111.
Vancouver KULOĞLU Z Çölyak Hastalığı. . 2014; 105 - 111.
IEEE KULOĞLU Z "Çölyak Hastalığı." , ss.105 - 111, 2014.
ISNAD KULOĞLU, Zafer. "Çölyak Hastalığı". (2014), 105-111.
APA KULOĞLU Z (2014). Çölyak Hastalığı. Türkiye Çocuk Hastalıkları Dergisi, 8(2), 105 - 111.
Chicago KULOĞLU Zafer Çölyak Hastalığı. Türkiye Çocuk Hastalıkları Dergisi 8, no.2 (2014): 105 - 111.
MLA KULOĞLU Zafer Çölyak Hastalığı. Türkiye Çocuk Hastalıkları Dergisi, vol.8, no.2, 2014, ss.105 - 111.
AMA KULOĞLU Z Çölyak Hastalığı. Türkiye Çocuk Hastalıkları Dergisi. 2014; 8(2): 105 - 111.
Vancouver KULOĞLU Z Çölyak Hastalığı. Türkiye Çocuk Hastalıkları Dergisi. 2014; 8(2): 105 - 111.
IEEE KULOĞLU Z "Çölyak Hastalığı." Türkiye Çocuk Hastalıkları Dergisi, 8, ss.105 - 111, 2014.
ISNAD KULOĞLU, Zafer. "Çölyak Hastalığı". Türkiye Çocuk Hastalıkları Dergisi 8/2 (2014), 105-111.